Home
|
Contact Us
|
Sitemap
Overview
Management Team
Board of Directors
Scientific Advisory Board
Careers
Current Openings
Benefits
About Pathogen Inactivation
Conventional Blood Testing
International Consensus Conference on Pathogen Inactivation
Glossary of Terms
How INTERCEPT Works
Product Pipeline
Commercializing The INTERCEPT System
The INTERCEPT Blood System
Case Study
Abstracts
Archived Abstracts
Publications
Archived Publications
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
Annual Meeting
Stock Information
SEC Filings
Information Request
Investor Contacts
RSS Feeds
Global Links
Management Team
Investors
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
Annual Meeting
Stock Information
SEC Filings
Information Request
Investor Contacts
RSS Feeds
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
Annual Meeting
Stock Information
SEC Filings
Information Request
Investor Contacts
RSS Feeds
SEC Filings
All Form Types
Annual Filings
Quarterly Filings
Current Reports
Proxy Filings
Registration Statements
Other Filings
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
Date
Filing
Description
Download
January 11, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
January 11, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
January 10, 2012
EFFECT
Effectiveness Order
January 09, 2012
SC 13G/A
Amended Statement of Ownership
January 06, 2012
S-3/A
Securities Registration Statement (simplified form)
January 06, 2012
4
Statement of Changes in Beneficial Ownership
January 05, 2012
4
Statement of Changes in Beneficial Ownership
January 05, 2012
4
Statement of Changes in Beneficial Ownership
January 05, 2012
4
Statement of Changes in Beneficial Ownership
January 05, 2012
4
Statement of Changes in Beneficial Ownership
© 2012 Cerus Corporation
Legal
|
Privacy
Powered By Q4 Web Systems
3.5.18.3156